AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Comparison of Knee Muscle Function After Suprapatellar and Infrapatellar Tibial Nailing in Patients With Tibial Shaft Fractures

Recruitingn/aAges 18 Years - 65 YearsAllProf. Dr. Cemil Tascıoglu Education and Research …
💬

In plain words

What the trial is, and whether it could suit you

The goal of this observational study is to compare the recovery of knee muscle strength and function in adults aged 18 to 65 years with a fracture in the middle part of the shinbone. All participants are treated with an intramedullary nail, which is a metal rod placed inside the shinbone. The nail is inserted through a surgical opening either above or below the kneecap. The main question this study aims to answer is: Does the recovery of the muscles that straighten the knee differ between the suprapatellar approach, performed above the kneecap, and the infrapatellar approach, performed below the kneecap? Researchers will compare participants who received the suprapatellar approach with those who received the infrapatellar approach. The treating surgical team chooses the approach as part of routine medical care. The researchers do not assign participants to either surgical approach. P

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: Age between 18 and 65 years Acute tibial shaft fracture classified as AO type 42 Treatment with intramedullary nailing using a suprapatellar or infrapatellar approach Provision of written informed consent to participate in the study Exclusion Criteria: Previous knee surgery. Concomitant knee ligament injury. Intra-articular fracture. Bilateral fractures. Neurovascular injury. Multiple trauma that may affect knee extensor strength, including an ipsilateral femoral fracture or pelvic fracture.
💊

What it tests

  • Infrapatellar Tibial Intramedullary Nailing
  • Suprapatellar Tibial Intramedullary Nailing
📍

Where

1 site
T.C. İstanbul Prof. Dr. Cemil Taşcıoğlu City Hospital
Istanbul, Turkey (Türkiye)
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy